IBD is associated with increased serum and tissue levels of pro-inflammatory cytokines, including TNF-α and IL-1b, which drive intestinal inflammation and lead to an impaired epithelial barrier function [52,53,54]. This evidence concerns the gene TNF and inflammatory bowel disease.